Aldose reductase in the etiology of diabetic complications: 2. Nephropathy

Watkins, 1985, Diabetic nephropathy—prevalence, complications and treatment, Diabetic Medicine, 2, 7, 10.1111/j.1464-5491.1985.tb00584.x Mogensen, 1985, Pathophysiology of renal changes in diabetes, Practical Diabetes, 2, 12, 10.1002/pdi.1960020306 Christiansen, 1981, Decreased kidney size, glomerular filtration rate and renal plasma flow in short term insulin dependent diabetes, Diabetologia, 20, 451, 10.1007/BF00253406 Bosch, 1985, Diabetic nephropathy: response to protein loading, Kidney Int, 27, 241A Mogensen, 1985, Microalbuminuria: an early marker of renal involvement in diabetes, Uremia Invest, 9, 85, 10.3109/08860228509088195 Viberti, 1982, Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus, Lancet, i, 1430, 10.1016/S0140-6736(82)92450-3 Parving, 1982, Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion, Acta Endocrinol (Copenh), 100, 550, 10.1530/acta.0.1000550 Mogensen, 1984, Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes, N Engl J Med, 310, 356, 10.1056/NEJM198402093100605 Jarrett, 1984, Microalbuminuria predicts mortality in non-insulin-dependent diabetes, Diabetic Medicine, 1, 17, 10.1111/j.1464-5491.1984.tb01915.x Parving, 1983, Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy, Lancet, i, 1175, 10.1016/S0140-6736(83)92462-5 Andersen, 1983, Diabetic nephropathy in Type I (insulin-dependent) diabetes: an epidemiologial study, Diabetologia, 25, 496, 10.1007/BF00284458 Winocour, 1987, Influence of proteinuria on vascular disease, blood pressure and lipoproteins in insulin dependent diabetes mellitus, Br Med J, 294, 1648, 10.1136/bmj.294.6588.1648 Jensen, 1987, Coronary heart disease in young Type I (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors, Diabetologia, 30, 144, 10.1007/BF00274218 Borch-Johnsen, 1987, Proteinuria: value as a predictor of cardiovascular mortality in insulin dependent diabetes, Br Med J, 294, 1651, 10.1136/bmj.294.6588.1651 Osterby, 1972, Morphometric studies on the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening, Diabetologia, 8, 84, 10.1007/BF01235631 Osterby, 1975, Early phases in the development of diabetic glomerulopathy, Acta Med Scand, S1 Kroustrup, 1977, Glomerular size and structure in diabetes mellitus. III. Early enlargement of capillary surface, Diabetologia, 13, 207, 10.1007/BF01219701 Gundersen, 1977, Glomerular size and structure in diabetes mellitus. II. Late abnormalities, Diabetologia, 13, 43, 10.1007/BF00996326 Mauer, 1984, Structural-functional relationships in diabetic nephropathy, J Clin Invest, 74, 1143, 10.1172/JCI111523 Hommel, 1987, Effects of indomethacin on kidney function in Type I (insulin-dependent) diabetic patients with nephropathy, Diabetologia, 30, 78, 10.1007/BF00274575 Christiansen, 1985, Short-term inhibition of prostaglandin synthesis has no effect on the elevated glomerular filtration rate of early insulin dependent diabetes, Diabetic Medicine, 2, 17, 10.1111/j.1464-5491.1985.tb00586.x Wiseman, 1985, Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin dependent diabetes, N Engl J Med, 312, 617, 10.1056/NEJM198503073121004 Barnett, 1984, Specific thromboxane synthetase inhibitor and albumin excretion rate in insulin dependent diabetes, Lancet, i, 1322, 10.1016/S0140-6736(84)91820-8 Cohen, 1986, Reduction of microal-buminuria and glomerular filtration rate by dietary protein restriction in Type I (insulin-dependent) diabetic patients: an effect independent of blood glucose control and arterial pressure changes, Diabetologia, 29, 528A Marre, 1987, Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria, Br Med J, 294, 1448, 10.1136/bmj.294.6585.1448 Mogensen, 1986, Early glomerular hyperfiltration in insulin dependent diabetics and late nephropathy, Scand J Clin Lab Invest, 46, 201, 10.3109/00365518609083660 Feldt-Rasmussen, 1986, Effect of 2 years of strict metabolic control on the progression of incipient nephropathy in insulin dependent diabetes, Lancet, ii, 1300, 10.1016/S0140-6736(86)91433-9 Bending, 1986, Intermittent clinical proteinuria and renal function in diabetes: evolution and the effect of glycaemic control, Br Med J, 292, 83, 10.1136/bmj.292.6513.83 Nyberg, 1987, Impact of metabolic control in progression of clinical diabetic nephropathy, Diabetologia, 30, 82, 10.1007/BF00274576 Christiansen, 1985, The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure, Diabetic Medicine, 2, 97, 10.1111/j.1464-5491.1985.tb00608.x Berglund, 1985, Metabolic and blood pressure monitoring in diabetic renal failure, Acta Med Scand, 218, 401, 10.1111/j.0954-6820.1985.tb08865.x Mogensen, 1982, Long term antihypertensive treatment inhibiting progression of diabetic nephropathy, Br Med J, 285, 685, 10.1136/bmj.285.6343.685 Parving, 1987, Effect of antihypertensive treatment on kidney function in diabetic nephropathy, Br Med J, 294, 1443, 10.1136/bmj.294.6585.1443 Bjorck, 1986, Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy, Br Med J, 293, 471, 10.1136/bmj.293.6545.471 Flynn, 1982, Aldehyde reductases: monomeric NADPH-dependent oxidoreductases with multifunctional potential, Biochem Pharmacol, 31, 2705, 10.1016/0006-2952(82)90123-X Wirth, 1985, Immunohistochemical localisation of aldehyde and aldose reductase in human tissues, 231 Hayman, 1966, Aldose reductase activity in the lens and other tissues, Biochim Biophys Acta, 128, 474, 10.1016/0926-6593(66)90008-7 McDonald, 1987, Quantitation by radioimmunoassay of aldose reductase (ALR2) in normal and diabetic rats, 367 Kern, 1982, Immunohistochemical distribution of aldose reductase, Histochem J, 14, 507, 10.1007/BF01011860 Ludvigson, 1980, Immunohistochemical localisation of aldose reductase. II. Rat eye and kidney, Diabetes, 29, 450, 10.2337/diabetes.29.6.450 Terubayashi, 1987, Immunohistochemical localisation of aldose and aldehyde reductase in the kidney Beyer-Mears, 1983, Sorbinil inhibition of renal aldose reductase, 42, 858 Beyer-Mears, 1984, Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil, Diabetes, 33, 604, 10.2337/diabetes.33.6.604 Sato, 1987, Susceptibility of aldose and aldehyde reductase to inhibition Bagnasco, 1986, Predominant osmotically active organic solutes in rat and rabbit renal medullas, J Biol Chem, 261, 5872, 10.1016/S0021-9258(17)38464-8 Stribling, 1985, Properties of ICI 128,436, a novel aldose reductase inhibitor and its effects on diabetic complications in the rat, Metabolism, 34, 336, 10.1016/0026-0495(85)90223-9 Kikkawa, 1987, Evidence for existence of polyol pathway in cultured rat mesangial cells, Diabetes, 36, 240, 10.2337/diabetes.36.2.240 Boot-Handford, 1982, Flux through the sorbitol pathway in cultured monkey kidney epithelial cells, IRCS Med Sci, 10, 1005 Cohen, 1985, Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozotocin diabetes and its prevention by oral sorbinil, Diabetes, 34, 1071, 10.2337/diabetes.34.11.1071 Ulbrecht, 1985, Sodium-dependent myoinositol uptake in isolated renal glomeruli: possible inhibition by glucose, Diabetes, 34, 13A Greene, 1987, Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications, N Engl J Med, 316, 599, 10.1056/NEJM198703053161007 Cohen, 1985, Aldose reductase inhibition, glomerular metabolism and diabetic nephropathy, Diabetic Medicine, 2, 185, 10.1111/j.1464-5491.1985.tb00637.x Cohen, 1985, Binding of an aldose reductase inhibitor to renal glomeruli, Biochem Biophys Res Commun, 129, 530, 10.1016/0006-291X(85)90184-6 Garner, 1987, Direct stimulation of Na+-K+-ATPase and its glucosylated derivative by aldose reductase inhibitor, Diabetes, 36, 716, 10.2337/diabetes.36.6.716 Steer, 1985, Renal hypertrophy in experimental diabetes. Changes in pentose phosphate pathway activity, Diabetes, 34, 485, 10.2337/diabetes.34.5.485 Sochor, 1988, The effect of aldose reductase inhibitor “Statil” (ICI 128,436) on the glucose over-utilisation in kidney of diabetic rats, Biochem Pharmacol, 37, 3349, 10.1016/0006-2952(88)90649-1 Beyer-Mears, 1983, Diabetic renal hypertrophy diminished by aldose reductase inhibition, 42, 505 Sato, 1987, Effect of aldose reductase inhibitor (M79175) on thickness of renal glomerular basement membrane in streptozotocin (STZ) induced diabetic rats Mayhew TM, Lutchman M, Sharma AK: Personal communication. McCaleb, 1988, Prevention of urinary albumin excretion in 6 months streptozocin-diabetic rats with the aldose reductase inhibitor tolrestat, J Diabetic Complications, 2, 16, 10.1016/0891-6632(88)90020-7 Beyer-Mears, 1986, Diminished proteinuria in diabetes mellitus by sorbinil, an aldose reductase inhibitor, Pharmacology, 32, 52, 10.1159/000138152 Watanabe, 1987, A possible role of polyol pathway in diabetic nephropathy Tilton, 1987, Inhibitors of aldose reductase block diabetes-induced increases in blood flow and GFR and markedly reduced 24h urinary albumin excretion in the rat, Diabetes, 36, 43A Goldfarb, 1986, Amelioration of glomerular hyperfiltration in acute experimental diabetes mellitus by dietary myoinositol supplementation and aldose reductase inhibition, Trans Assoc Am Physicians, 99, 67 Kikkawa, 1986, Impaired contractile responsiveness of diabetic glomeruli to angiotensin II. A possible indication of mesangial dysfunction in diabetes mellitus, Biochem Biophys Res Commun, 136, 1185, 10.1016/0006-291X(86)90459-6 Dunn, 1986, Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury, J Hypertens, 4, S251 Kern, 1987, Kidney morphology in experimental hyperglycaemia, Diabetes, 36, 244, 10.2337/diabetes.36.2.244 Brownlee, 1984, Nonenzymatic glycosylation and the pathogenesis of diabetic complications, Ann Intern Med, 191, 527, 10.7326/0003-4819-101-4-527 Brownlee, 1986, Aminoguanidine prevents diabetes induced arterial wall protein crosslinking, Science, 232, 1629, 10.1126/science.3487117 Beyer-Mears, 1986, The polyol pathway, sorbinil and renal dysfunction, Metabolism, 35, 46, 10.1016/0026-0495(86)90187-3